Search
for
Sort by
Research 481–510 of 1000+
- Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata
- Two Clinically Unusual Cases of Folliculotropic Mycosis Fungoides: One with and the Other without Syringotropism
- Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Role of janus kinase inhibitors in the treatment of alopecia areata
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Human ClinicalPhenotype Associated with FOXN1 Mutations
- Radiation Dermatitis: Radiation-Induced Effects on the Structural and Immunological Barrier Function of the Epidermis
- CAQ Corner: Basic concepts of transplant immunology
- Role of <i>foxn1</i> in <i>Xenopus laevis</i> thymopoiesis.
- 0935 Unravelling the role of JAK3/TEC kinase signalling with ritlecitinib in alopecia areata lesional skin and alopecia areata-induced human hair follicles ex vivo
- LB922 CyTOF immune profiling uncovers sex- and race-specific differences and cellular biomarkers for biologic response in Hidradenitis suppurativa
- The Multi-Faceted Role of Gut Microbiota in Alopecia Areata
- 3D spheroid culture synchronizes heterogeneous MSCs into an immunomodulatory phenotype with enhanced anti-inflammatory effects
- Summary of the Preceding Three Alopecia Areata Research Summits: What’s Past Is Prologue
- A Case of Idiopathic Follicular Mucinosis Treated Successfully with Cyclosporine.
- 1385 Characterizing the expression of metabolic markers in alopecia areata
- Greasy hair against obesity
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Therapeutic efficacy and safety of Kang-ai injection combined with platinum-based doublet chemotherapy in advanced NSCLC: A meta-analysis
- Pathologic Quiz Case: A Cutaneous Nodule on the Left Temple
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis
- Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata
- Pathophysiology of the Behçet's Disease